X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34) 34
female (28) 28
hematology (28) 28
male (27) 27
index medicus (25) 25
middle aged (24) 24
life sciences (23) 23
adult (22) 22
aged (12) 12
multiple myeloma (12) 12
cancer (11) 11
immunology (10) 10
oncology (10) 10
[sdv.can]life sciences [q-bio]/cancer (9) 9
adolescent (9) 9
analysis (9) 9
abridged index medicus (8) 8
article (8) 8
chemotherapy (8) 8
stem cell transplantation (8) 8
transplantation (8) 8
young adult (8) 8
[ sdv.bbm ] life sciences [q-bio]/biochemistry, molecular biology (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
biochemistry, molecular biology (7) 7
multiple myeloma - therapy (7) 7
risk factors (7) 7
treatment outcome (7) 7
[sdv.bbm]life sciences [q-bio]/biochemistry, molecular biology (6) 6
care and treatment (6) 6
disease (6) 6
hematopoietic stem cells (6) 6
hemic and lymphatic diseases (6) 6
hodgkin lymphoma (6) 6
human health and pathology (6) 6
lymphoma (6) 6
mesh : humans (6) 6
mesh: humans (6) 6
patients (6) 6
safety (6) 6
therapy (6) 6
[ sdv.can ] life sciences [q-bio]/cancer (5) 5
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (5) 5
[sdv.imm]life sciences [q-bio]/immunology (5) 5
bone-marrow-transplantation (5) 5
combined modality therapy (5) 5
disease-free survival (5) 5
follow-up studies (5) 5
hematopoietic stem cell transplantation (5) 5
leukemia (5) 5
lymphomas (5) 5
mesh : multiple myeloma (5) 5
non-hodgkins-lymphoma (5) 5
transplantation, autologous (5) 5
[ sdv.imm ] life sciences [q-bio]/immunology (4) 4
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (4) 4
adults (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
autografts (4) 4
clinical trials (4) 4
cyclophosphamide (4) 4
dexamethasone (4) 4
france (4) 4
gene expression (4) 4
hodgkin disease - drug therapy (4) 4
hodgkin disease - mortality (4) 4
hodgkin disease - pathology (4) 4
immunotherapy (4) 4
mesh: female (4) 4
mesh: middle aged (4) 4
mesh: multiple myeloma (4) 4
methods (4) 4
multiple-myeloma (4) 4
plasma cells (4) 4
purpura (4) 4
research (4) 4
risk (4) 4
rituximab (4) 4
stem cells (4) 4
thrombocytopenia (4) 4
abvd (3) 3
aged, 80 and over (3) 3
b-lymphocytes (3) 3
bleomycin (3) 3
blood (3) 3
brentuximab vedotin (3) 3
case-control studies (3) 3
cell line, tumor (3) 3
cell proliferation (3) 3
children (3) 3
cyclophosphamide - administration & dosage (3) 3
database (3) 3
doxorubicin (3) 3
drug therapy (3) 3
efficacy (3) 3
epidemiology (3) 3
filgrastim (3) 3
genetics (3) 3
granulocyte colony-stimulating factor (3) 3
high-dose chemotherapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2019, Volume 94, Issue 6, pp. 635 - 640
The risk of venous thromboembolism (VTE) is higher in myeloma patients receiving immunomodulatory compounds. A VTE prophylaxis using low‐molecular‐weight... 
MULTIPLE-MYELOMA | ENOXAPARIN | DEXAMETHASONE | VENOUS THROMBOEMBOLISM | THROMBOSIS | LENALIDOMIDE | THROMBOPROPHYLAXIS | THALIDOMIDE | HEMATOLOGY
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3932 - 3932
Abstract Introduction: Continuous improvement in the management of Hodgkin Lymphoma (HL) has brought to favorable outcome for the majority of patients.... 
Life Sciences
Journal Article
Blood, ISSN 0006-4971, 01/2009, Volume 113, Issue 5, pp. 995 - 1001
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 04/2014, Volume 275, Issue 4, pp. 398 - 408
Objectives The aim of this study was to investigate whether the quadrivalent human papillomavirus (HPV) vaccine Gardasil is associated with a change in the... 
vaccine safety | autoimmune disorders | human papillomavirus vaccine | systematic case–control study | human papillomavirus | vaccination | Vaccine safety | Human papillomavirus | Systematic case-control study | Human papillomavirus vaccine | Autoimmune disorders | Vaccination | SYSTEMIC-LUPUS-ERYTHEMATOSUS | IMMUNE THROMBOCYTOPENIC PURPURA | systematic case-control study | GUILLAIN-BARRE-SYNDROME | CHILDREN | IMMUNIZATION | MEDICINE, GENERAL & INTERNAL | MULTIPLE-SCLEROSIS | DATABASE | SURVEILLANCE | INFLUENZA VACCINATION | DIAGNOSTIC-CRITERIA | Autoimmune Diseases - epidemiology | France - epidemiology | Humans | Mass Vaccination - statistics & numerical data | Risk Factors | Autoimmune Diseases - immunology | Autoimmune Diseases - etiology | Case-Control Studies | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Incidence | Alphapapillomavirus | Young Adult | Connective Tissue Diseases - immunology | Papillomavirus Infections - prevention & control | Purpura, Thrombocytopenic, Idiopathic - immunology | Adolescent | Multiple Sclerosis - immunology | Papillomavirus Infections - immunology | Papillomavirus Vaccines - adverse effects | Adult | Female | Diabetes Mellitus, Type 1 - immunology | Papillomavirus Vaccines - administration & dosage | Papillomaviruses | AIDS vaccines | Guillain-Barre syndrome | Type 1 diabetes | Analysis | Oral contraceptives | Life Sciences
Journal Article
Blood, ISSN 0006-4971, 04/2004, Volume 103, Issue 8, pp. 3148 - 3157
Identification of growth factors in neoplasias may be a target for future therapies by blocking either growth factor receptor interaction or the induced... 
B-LYMPHOCYTE STIMULATOR | TNF RECEPTOR | SYSTEMIC-LUPUS-ERYTHEMATOSUS | NECROSIS-FACTOR FAMILY | MATURATION PROTEIN | MONOCLONAL-ANTIBODY | GROWTH-FACTOR | MALIGNANT PLASMA-CELLS | HEMATOLOGY | NF-KAPPA-B | HUMAN MULTIPLE-MYELOMA | Interleukin-6 - antagonists & inhibitors | Apoptosis - drug effects | Humans | Tumor Necrosis Factor-alpha - genetics | Neuropeptides - physiology | RNA, Messenger - metabolism | RNA, Neoplasm - metabolism | Receptors, Tumor Necrosis Factor - physiology | Multiple Myeloma - drug therapy | Dexamethasone - pharmacology | Membrane Proteins - physiology | Base Sequence | Plasma Cells - metabolism | Membrane Proteins - metabolism | Neuropeptides - genetics | Nuclear Proteins - genetics | Interleukin-6 - metabolism | Multiple Myeloma - physiopathology | Receptors, Tumor Necrosis Factor - genetics | Receptors, Tumor Necrosis Factor - metabolism | Gene Expression | Signal Transduction | Membrane Proteins - genetics | RNA, Messenger - genetics | Transmembrane Activator and CAML Interactor Protein | B-Cell Activation Factor Receptor | B-Cell Maturation Antigen | Multiple Myeloma - pathology | B-Cell Activating Factor | Tumor Necrosis Factor-alpha - physiology | Cell Line, Tumor | RNA, Neoplasm - genetics | Nuclear Proteins - physiology | Apoptosis - physiology | Multiple Myeloma - genetics | Dexamethasone | Hematology | Biochemistry, Molecular Biology | Neuropeptides | Nuclear Proteins | Interleukin-6 | Membrane Proteins | Life Sciences | Human health and pathology | Apoptosis | Multiple Myeloma | Cancer | pathology | RNA | Receptors | genetics | pharmacology | Tumor | Plasma Cells | Cell Line | drug therapy | physiology | drug effects | Messenger | Tumor Necrosis Factor-alpha | antagonists & inhibitors | Neoplasm | physiopathology | metabolism | Tumor Necrosis Factor
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 04/2018, Volume 100, Issue 5, pp. 1133 - 1145
Journal Article
Cancer, ISSN 0008-543X, 12/2008, Volume 113, Issue 12, pp. 3323 - 3330
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2013, Volume 162, Issue 2, pp. 240 - 249
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5108 - 5108
Abstract In July 2004 in Europe, radioimmunotherapy (RIT) with Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) obtained marketing authorization (MA) for follicular... 
Journal Article